<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND/OBJECTIVE: The efficacy of a direct factor (F)Xa inhibitor, ZK-807834, was compared with indirect inhibition by enoxaparin for inhibition and deaggregation of <z:hpo ids='HP_0011009'>acute</z:hpo> platelet-rich <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">thrombi</z:e> in a well-characterized porcine carotid injury model </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: A crush injury was performed on a randomly chosen carotid artery and the <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> allowed to propagate for 30 min </plain></SENT>
<SENT sid="2" pm="."><plain>Pigs then received intravenous drug for 35 min: ZK-807834-Dose 1 (40 microg kg(-1) bolus + 1.5 microg kg(-1) min(-1) infusion, n=6); ZK-807834-Dose 2 (20 microg kg(-1) bolus + 0.75 microg kg(-1) min(-1) infusion; n=6); enoxaparin (1 mg kg(-1) bolus; n=6); or saline (n=6) </plain></SENT>
<SENT sid="3" pm="."><plain>Five minutes after drug initiation, the contralateral artery was injured </plain></SENT>
<SENT sid="4" pm="."><plain><z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">Thrombus</z:e> size was monitored by scintillation detection of autologous 111In-platelets </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: The prothrombin time ratio was 2.2 +/- 0.1; 1.4 +/- 0.3; 1.2 +/- 0.9 and 1.1 +/- 0.2, respectively </plain></SENT>
<SENT sid="6" pm="."><plain>ZK-807834-Dose 1 significantly inhibited carotid platelet deposition (525 +/- 226 x 10(6) cm(-2); P = 0.008), whereas ZK-807834-Dose 2 (2325 +/- 768) and enoxaparin (1236 +/- 383) were not different from saline (2776 +/- 642) </plain></SENT>
<SENT sid="7" pm="."><plain><z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">Thrombus</z:e> deaggregation was greatest for animals receiving ZK-807834-Dose 1 (473 +/- 185) </plain></SENT>
<SENT sid="8" pm="."><plain>Neither ZK-807834-Dose 2 (1588 +/- 480) nor enoxaparin (1618 +/- 686) was different from saline control (2222 +/- 598) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Direct FXa inhibition with ZK-807834, at a prothrombin time ratio of 2.2, effectively inhibits <z:mp ids='MP_0005048'>thrombosis</z:mp> and promptly deaggregates <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">thrombi</z:e> induced by arterial injury </plain></SENT>
<SENT sid="10" pm="."><plain>In contrast, indirect FXa inhibition with enoxaparin was ineffective </plain></SENT>
</text></document>